Preclinical studies with prothymosin α1 on mononuclear cells from tumor patients
- 31 October 1997
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 19 (9-10) , 493-500
- https://doi.org/10.1016/s0192-0561(97)00079-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prothymosin α1 Effects on IL-2-Induced Expression of LFA-1 on Lymphocytes and Their Adhesion to Human Umbilical Vein Endothelial CellsJournal of Interferon & Cytokine Research, 1997
- Prothymosin .alpha.: A Biologically Active Protein with Random Coil ConformationBiochemistry, 1995
- Prothymosin α1 modulates lymphokine-activated killer cell activity and IL-2 production by peripheral blood lymphocytes from melanoma patients in vitroInternational Journal of Immunopharmacology, 1995
- Prothymosin α restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancerInternational Journal of Cancer, 1993
- Promotion of murine antitumour activity by prothymosin α treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor αCancer Immunology, Immunotherapy, 1992
- Depressed Levels of Granular Lymphocytes with Natural Killer (NK) Cell Function in 247 Cancer PatientsAnnals of Surgery, 1983
- Monocyte dysfunction in human cancerCancer, 1983